NCT04632316 2022-06-21
A Trial to Evaluate the Safety and Efficacy of oNKord® in Subjects With Acute Myeloid Leukemia
Glycostem Therapeutics BV
Phase 1/2 Unknown
Glycostem Therapeutics BV
Huazhong University of Science and Technology
Hebei Senlang Biotechnology Inc., Ltd.